|Christina Bennett, MS, is an independent medical journalist based in New Mexico. She is a member of the Association of Healthcare Journalists and the National Association of Science Writers and was one of a dozen journalists selected for the 2017 National Cancer Reporting Fellowships. She writes about a variety of medical topics, including oncology, healthcare policy, and cell and gene therapies.
|Leslie Burgess, MA, is a writer and member of the American Medical Writers Association living in Southern California. She has been working in the fields of science and medicine for more than 20 years and holds a BS in journalism from Monmouth University. Leslie is a volunteer for California State Parks and an avid photographer.
|Bryant Furlow is medical journalist working at the crossroads of research, clinical practice, and public policy. His work has appeared in the Lancet, New Scientist, and Oncology Nurse Advisor.
|Andy Kistler, MD, PharmD writes various articles for Cancer Therapy Advisor, including those that appear in the "In the Clinic" column. He is a gastroenterologist with interests in GI oncology, immunotherapy, the gut microbiome, and clinical pharmacology.
|Leah Lawrence is a freelance health writer and editor. She has contributed to trade, consumer, and medical association publications and websites focused on hematology/oncology, cardiology, primary care, endocrinology, and general health.
|Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.
CANCER THERAPY ADVISOR STAFF
Stephan Cho, Digital Content Editor
Cancer Therapy Advisor
275 7th Avenue, 10th Floor
New York, NY 10011
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Clinical Applications of Liquid Biopsies in Cancer
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Immunotherapy in Glioblastoma: Peaks and Pits
- Opinion: Understanding the FDA's Take on Cannabidiol
- Investigational Antiandrogen Drug Delays Metastasis in CRPC
- Polymorphism in HSD3B1 as a Potential Prognostic Biomarker in Prostate Cancer
- Opioid Use and Cancer
- OS and PFS End Points Not Met in Phase 3 Trial of Pembrolizumab in Advanced HCC
- No Benefit Observed With Osimertinib Plus Durvalumab in EGFR-Mutated NSCLC
- Evidence of the Role of Circulating Insulin in Renal Cell Carcinoma Risk